# 23mofang Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/23mofang-co

- Industry: Biotechnology
- Headquarters: Chengdu, China
- Website: www.23mofang.com
- Total disclosed funding: $32M
- Latest round: Series B (May 31, 2018)
- Investors on record: 9

## About

Based in Sichuan, China and established in 2015, 23mofang Co., Ltd operates as a genetic testing service provider which offers genetic information and medical consultation services for patients and health care providers.

## Funding rounds

- Series B, May 31, 2018, $9.7M — SB China Venture Capital, CD Capital, 3E Bioventures Capital, MPC, Alwin Capital
- Series B, Mar 6, 2018, $16M — Hanwang Technology Co., Ltd., MPC, Yahui Precise Medical Care Fund, Desun Capital
- Series B, Aug 2, 2017, $6M — Hanwang Technology Co., Ltd., Fenghou Capital, Yahui Precise Medical Care Fund, Desun Capital
- Angel, Mar 1, 2015, $0.8M — Fenghou Capital

## Investors

- Fenghou Capital (https://capitalatlas.ai/funds/fenghou-capital) — Angel, Series B
- Hanwang Technology Co., Ltd. — Series B
- Yahui Precise Medical Care Fund — Series B
- Desun Capital (https://capitalatlas.ai/funds/desun-capital) — Series B
- MPC — Series B
- SB China Venture Capital (https://capitalatlas.ai/funds/sb-china-venture-capital) — Series B
- CD Capital — Series B
- 3E Bioventures Capital (https://capitalatlas.ai/funds/3e-bioventures-capital) — Series B
- Alwin Capital — Series B